Skip to Content
Merck
  • Short-Chain Fatty Acids Improve Poststroke Recovery via Immunological Mechanisms.

Short-Chain Fatty Acids Improve Poststroke Recovery via Immunological Mechanisms.

The Journal of neuroscience : the official journal of the Society for Neuroscience (2020-01-01)
Rebecca Sadler, Julia V Cramer, Steffanie Heindl, Sarantos Kostidis, Dene Betz, Kielen R Zuurbier, Bernd H Northoff, Marieke Heijink, Mark P Goldberg, Erik J Plautz, Stefan Roth, Rainer Malik, Martin Dichgans, Lesca M Holdt, Corinne Benakis, Martin Giera, Ann M Stowe, Arthur Liesz
ABSTRACT

Recovery after stroke is a multicellular process encompassing neurons, resident immune cells, and brain-invading cells. Stroke alters the gut microbiome, which in turn has considerable impact on stroke outcome. However, the mechanisms underlying gut-brain interaction and implications for long-term recovery are largely elusive. Here, we tested the hypothesis that short-chain fatty acids (SCFAs), key bioactive microbial metabolites, are the missing link along the gut-brain axis and might be able to modulate recovery after experimental stroke. SCFA supplementation in the drinking water of male mice significantly improved recovery of affected limb motor function. Using in vivo wide-field calcium imaging, we observed that SCFAs induced altered contralesional cortex connectivity. This was associated with SCFA-dependent changes in spine and synapse densities. RNA sequencing of the forebrain cortex indicated a potential involvement of microglial cells in contributing to the structural and functional remodeling. Further analyses confirmed a substantial impact of SCFAs on microglial activation, which depended on the recruitment of T cells to the infarcted brain. Our findings identified that microbiota-derived SCFAs modulate poststroke recovery via effects on systemic and brain resident immune cells.SIGNIFICANCE STATEMENT Previous studies have shown a bidirectional communication along the gut-brain axis after stroke. Stroke alters the gut microbiota composition, and in turn, microbiota dysbiosis has a substantial impact on stroke outcome by modulating the immune response. However, until now, the mediators derived from the gut microbiome affecting the gut-immune-brain axis and the molecular mechanisms involved in this process were unknown. Here, we demonstrate that short-chain fatty acids, fermentation products of the gut microbiome, are potent and proregenerative modulators of poststroke neuronal plasticity at various structural levels. We identified that this effect was mediated via circulating lymphocytes on microglial activation. These results identify short-chain fatty acids as a missing link along the gut-brain axis and as a potential therapeutic to improve recovery after stroke.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Rose bengal, certified by the Biological Stain Commission, Dye content ≥80 %
Supelco
Metronidazole, VETRANAL®, analytical standard